Search

Congratulations to Katherine and Swapnil for winning the Regional Finals for Siemens Foundation 2017! News articles from their high school: Aquila and Winged Post; Interview with Mecury News Links to their Siemen's Regional Finalists Bio and Project Abstracts

Dr. Heng's abstract, “Deep Learning Image Analysis of Benign Breast Disease to Identify Subsequent Risk of Breast Cancer” has been selected as an oral presentation for the 8th Annual Dana-Farber/Harvard Cancer Center Celebration of Early Career Investigators in Cancer Research.

Drs. Heng and Baker were invited to contribute a new topic for PathologyOutlines.com - Transgender Breast Pathology. PathologyOutlines.com is a highly accessed reference site by practicing pathologists.

Dr. Heng joins the Program Commitee of the first workshop on Applications of Medical AI (AMAI), taking place as a Satellite Event of MICCAI 2022 on Sep 18 2022 in Singapore. https://sites.google.com/view/amai2022/home#h.nbe1l6goxbom

Dr. Heng presented a talk, "Using miRNA profiling technologies to assess breast cancer patient response to platinum-based chemotherapy" at the 2023 Harvard Institute for RNA Medicine / MiRXES workshop. https://www.linkedin.com/feed/update/urn:li:activity:7060326293812219904?utm_source=share&utm...

Dr Gerburg Wulf will be presenting a talk and poster for the team at the Basser Center for BRCA Scientific Symposium, "Early eradication of BRCA1/2mut tumors."

“ Toker Cell Hyperplasia in the Nipple-areolar Complex of Transmasculine Individuals”, published in Modern Pathology, has been selected as Best Clinical Paper 2023 by the BIDMC Cancer Research Institute.

The Heng/Wulf team abstract, "Biological sex-linked immune modulation but not cross-sex estrogen therapy reduces the efficacy of PARP inhibition in the treatment of Brca1 breast tumors" has been selected for Poster Spotlight presentation at the SABCS 2024.